Αποτελέσματα Αναζήτησης
The Alzheimer’s Disease Neuroimaging Initiative (ADNI) is a longitudinal, multi-center, observational study. The overall goal of ADNI is to validate biomarkers for Alzheimer’s disease (AD) clinical trials.
- About
The Alzheimer’s Disease Neuroimaging Initiative (ADNI) is a...
- News & Publications
The Alzheimer’s Disease Neuroimaging Initiative (ADNI) is a...
- HELP / FAQ
The Image & Data Archive (IDA) is a user-friendly...
- About
The Image & Data Archive (IDA) is a user-friendly environment to archive, search, share, track and obtain ADNI data. A valid user account and an approved ADNI Data Use Application are required to access the ADNI images and data. Access Data page – Please review for more information on obtaining access to ADNI data.
30 Ιουν 2011 · Clinical data from the ADNI 1, ADNI GO and ADNI 2 phases of the project are now available in the the ADNI Repository (IDA). Once logged in, you may peruse and download assessment, medical history, biospecimen and other data from the DOWNLOAD | Study Data menu. See INSTRUCTIONS for more information.
The Alzheimer’s Disease Neuroimaging Initiative (ADNI) is a landmark partnership and study supported by the FNIH that involves identifying and validating biomarkers to detect the progression of Alzheimer’s Disease (AD).
The ADNI4 study is the fourth in a series of trials since 2004 to identify markers for diagnosing and tracking the progression of Alzheimer's disease. In this study, older adults with normal cognition, mild cognitive impairment, or Alzheimer's will undergo medical and cognitive evaluations, blood biomarker and genetic tests, PET and MRI brain ...
The Alzheimer’s Disease Neuroimaging Initiative (ADNI) is a longitudinal multicenter study designed to develop clinical, imaging, genetic, and biochemical biomarkers for the early detection and tracking of Alzheimer’s disease (AD).
Alzheimer's Disease Neuroimaging Initiative (ADNI) is a multisite study that aims to improve clinical trials for the prevention and treatment of Alzheimer's disease (AD). [1] This cooperative study combines expertise and funding from the private and public sector to study subjects with AD, as well as those who may develop AD and controls with ...
